We are hiring! Click to View Open Positions.

Posters & Presentations

September 2021

World Muscle Society 2021 Virtual Congress

Insights into the Potential Pharmacological Effects of Apitegromab in Health and Disease: Data from Preclinical and Clinical Studies (EP.277)

View This Poster

September 2021

World Muscle Society 2021 Virtual Congress

Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (LBP.10)

View This Poster

June 2021

Virtual 2021 7th Congress of the European Academy of Neurology (EAN)

Apitegromab, an Investigational Anti-proMyostatin Monoclonal Antibody for Spinal Muscular Atrophy: Phase 2 Results (Presentation)

View This Poster

June 2021

2021 American Society of Clinical Oncology (ASCO) Annual Meeting

First-in-Human Phase 1 Trial (DRAGON) of SRK-181: A Potential First-in-Class Selective Latent TGFβ1 Inhibitor, Alone or in Combination with Anti-PD-(L)1 Treatment in Patients with Advanced Solid Tumors

View This Poster

May 2021

16th International Congress on Neuromuscular Diseases (ICNMD 2021)

TOPAZ: Phase 2 Study Evaluating Efficacy and Safety of Apitegromab in Later-Onset Spinal Muscular Atrophy; An Interim Analysis

View This Poster

April 2021

2021 Virtual American Academy of Neurology (AAN) Annual Meeting

A Phase 2 Study to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): Interim Analysis Results

View This Poster